Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
S2Medical ABOSTO:S2M -25.00% EV-to-EBIT is -0.74 as of Aug. 25, 2026. The stock has 5 warning signs investors should review. Among 476 Medical Devices & Instruments companies, S2Medical AB ranks worse than 210083.82% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
S2Medical AB's Enterprise Value for the quarter that ended in Dec. 2025 was kr8.77 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. S2Medical AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-9.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB EV-to-EBIT Related Terms
S2Medical AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for S2Medical AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:S2M vs ISRG, BDX, MDLN: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, S2Medical AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where S2Medical AB's EV-to-EBIT falls into.
S2Medical AB's current Enterprise Value is kr7.09 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. S2Medical AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-9.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB (OSTO:S2M) has a EV-to-EBIT of -0.74 as of Aug. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on S2Medical AB and its competitors. According to the industry distribution chart, S2Medical AB ranks #999999 out of 476 companies in the Medical Devices & Instruments industry.
Is S2Medical AB's EV-to-EBIT too high?
S2Medical AB's current EV-to-EBIT is -0.74. Based on the distribution chart, S2Medical AB ranks #999999 out of 476 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does S2Medical AB's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #999999 out of 476 companies for EV-to-EBIT. This places S2Medical AB in the lower half of its industry. The industry median EV-to-EBIT is 19.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.00, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on S2Medical AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current EV-to-EBIT is -0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
Based on GuruFocus' analysis, S2Medical AB (OSTO:S2M) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.01, compared to a current price of kr0.00 — trading 52% below its estimated fair value. The current EV-to-EBIT is -0.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For S2Medical AB (OSTO:S2M), the current EV-to-EBIT is -0.74 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:S2M has been successfully added to your 
